Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of WH-1 Ointment in Chronic Diabetic Foot Ulcers
NCT02353273Phase 1Completed
- Sponsor
- Oneness Biotech Co., Ltd.
- Start
- Jul 2015
- Primary completion
- Jul 2016
- Modality
- Botanical drug
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Fespixon in diabetic foot ulcer (DFU), sponsored by Oneness Biotech Co., Ltd. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Infinity at Day 1, Area Under the Concentration-Time Curve From Time Zero to the Last Measurable Concentration at Day 1 and 3 more. Started Jul 2015; status: completed.
02
Drugs
Fespixon
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02353273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353273.